Background
The current study aimed to produce AgNPs through a biogenic approach and assessed for their significant anti-pathogenic activities against multi-drug resistant ESKAPE pathogens. The biogenic AgNPs were synthesized through non-toxic manner and characterized by using UV-vis, XRD, DLS, TGA-DTA, FTIR, SEM along with EDX and UHRTEM were used to determine the absorption spectra, shape, size, thermal behaviour, functional groups, morphology, elemental constituents and defined particle size distribution profile, respectively. The AgNPs were evaluated for their anti-pathogenic effects against eleven strains of multi drug resistant ESKAPE pathogens by growth inhibition, biofilm adhesion, growth kinetics and Live/dead assays.Results
The inhibitory range of AgNPs concentration was investigated as higher zones at escalating concentration (50 to 200 µg/ml). The growth kinetics of inhibition of all tested pathogens occurred after 4 hrs of treatment with AgNPs. Adherence assay exhibited highest inhibition in E. faecium (MCC 2763), P. aeruginosa (MTCC 1688) and E. species (MCC 2296) at 100µg/ml of AgNPs. The exposure of AgNPs increased the dead cell and consequently reduced cells density with AgNPs comparable with the effect of commercial antibiotics. The selected pathogens were found more sensitive to AgNPs than Cefotaxime/AgNO3 with the statistically significant (P < 0.05).Conclusion
The emergence of drug resistance in ESKAPE pathogens are the extending reason for nosocomial infections, limiting the choice of antibiotics. Nanomaterials have been considered potential agents to prevent infections. Therefore, present study showed the broad spectrum potential and anti-pathogenic potency of biogenic AgNPs as an alternative to conventional antimicrobial agents.